Novel tumour markers: a diagnostic role in pancreatic cancer?
نویسندگان
چکیده
منابع مشابه
Prognostic Tumour Markers in Pancreatic Cancer
Academic Dissertation To be presented for public examination with the permission of This thesis is based on the following original publications, which are referred to in the text by their Roman numerals I-V. Loss of p27 expression is associated with poor prognosis in stage I-II pancreatic cancer. Syndecan-1 expression – a novel prognostic marker in pancreatic cancer. Tenascin C expression is up...
متن کاملA novel serum metabolomics-based diagnostic approach to pancreatic cancer.
BACKGROUND To improve the prognosis of patients with pancreatic cancer, more accurate serum diagnostic methods are required. We used serum metabolomics as a diagnostic method for pancreatic cancer. METHODS Sera from patients with pancreatic cancer, healthy volunteers, and chronic pancreatitis were collected at multiple institutions. The pancreatic cancer and healthy volunteers were randomly a...
متن کاملDiagnostic value of tumour markers in pleural effusions
Introduction We investigated whether tumour markers carcinoembryonic antigen (CEA), neuron-specific enolase (NSE), cancer antigen 125 (CA-125), and cytokeratin 19 fragment (CYFRA 21-1) in pleural effusions and serum can be used to distinguish pleural effusion aetiology. Materials and methods During the first thoracentesis, we measured pleural fluid and serum tumour marker concentrations and c...
متن کاملCarbohydrate markers of pancreatic cancer.
Pancreatic cancer is the fourth most common cause of death from cancer in the world and the sixth in Europe. Pancreatic cancer is more frequent in males than females. Worldwide, following diagnosis of pancreatic cancer, <2% of patients survive for 5 years, 8% survive for 2 years and <50% survive for only approx. 3 months. The biggest risk factor in pancreatic cancer is age, with a peak of morbi...
متن کاملDiagnostic Management of Pancreatic Cancer
Pancreatic cancer is one of the most deadly solid tumors, with an overall 5-year survival rate of less than 5%. Due to a non-specific clinical presentation, it is often diagnosed at an advanced stage and is rarely amenable for curative treatment. Therefore early diagnosis and appropriate staging are still essential to define the best care and to improve patient survival. Several imaging modalit...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Cancer
سال: 1994
ISSN: 0007-0920,1532-1827
DOI: 10.1038/bjc.1994.313